4.8 Article

Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses

Journal

IMMUNITY
Volume 51, Issue 4, Pages 709-+

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2019.09.005

Keywords

-

Categories

Funding

  1. Boehringer Ingelheim Fonds PhD fellowship
  2. NIH [1K08HL130540, F32AI138458, R01 HL122531, R01 AI130019, R01 AI139536, 1K08AI123516]
  3. Howard Hughes Medical Institute
  4. Food Allergy Scientific Initiative
  5. Klarman Cell Observatory at the Broad Institute

Ask authors/readers for more resources

Neuroimmune interactions have emerged as critical modulators of allergic inflammation, and type 2 innate lymphoid cells (ILC2s) are an important cell type for mediating these interactions. Here, we show that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor. CGRP potently inhibited alarmin-driven type 2 cytokine production and proliferation by lung ILC2s both in vitro and in vivo. CGRP induced marked changes in ILC2 expression programs in vivo and in vitro, attenuating alarmin-driven proliferative and effector responses. A distinct subset of ILCs scored highly for a CGRP-specific gene signature after in vivo alarmin stimulation, suggesting CGRP regulated this response. Finally, we observed increased ILC2 proliferation and type 2 cytokine production as well as exaggerated responses to alarmins in mice lacking the CGRP receptor. Together, these data indicate that endogenous CGRP is a critical negative regulator of ILC2 responses in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available